Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about updates

27 Mar 2019 Evaluate

In accordance with Regulation 11 of the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018 (the Buyback Regulations), Ajanta Pharma has informed that the Company has extinguished 7,69,230 fully paid up Equity Shares of Rs 2/- each.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1882.10
Dr. Reddys Labs. 1388.85
Cipla 1431.05
Lupin 1960.85
Zydus Lifesciences 1203.00
View more..